<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8709159</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3902</journal-id>
<journal-id journal-id-type="nlm-ta">Free Radic Biol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Free Radic. Biol. Med.</journal-id>
<journal-title-group>
<journal-title>Free radical biology &amp; medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0891-5849</issn>
<issn pub-type="epub">1873-4596</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29940351</article-id>
<article-id pub-id-type="pmc">6233711</article-id>
<article-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.06.024</article-id>
<article-id pub-id-type="manuscript">NIHMS995253</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wert</surname>
<given-names>Katherine J.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Velez</surname>
<given-names>Gabriel</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cross</surname>
<given-names>Madeline R.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wagner</surname>
<given-names>Brett A.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Teoh-Fitzgerald</surname>
<given-names>Melissa L.</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buettner</surname>
<given-names>Garry R.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McAnany</surname>
<given-names>J. Jason</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olivier</surname>
<given-names>Alicia</given-names>
</name>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsang</surname>
<given-names>Stephen H.</given-names>
</name>
<xref ref-type="aff" rid="A8">h</xref>
<xref ref-type="aff" rid="A9">i</xref>
<xref ref-type="aff" rid="A10">j</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harper</surname>
<given-names>Matthew M.</given-names>
</name>
<xref ref-type="aff" rid="A11">k</xref>
<xref ref-type="aff" rid="A12">l</xref>
<xref ref-type="aff" rid="A13">m</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Domann</surname>
<given-names>Frederick E.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bassuk</surname>
<given-names>Alexander G.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahajan</surname>
<given-names>Vinit B.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A14">n</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA, United States</aff>
<aff id="A2"><label>b</label>Omics Laboratory, Stanford University, Palo Alto, CA, United States</aff>
<aff id="A3"><label>c</label>Department of Pediatrics, University of Iowa, Iowa City, IA, United States</aff>
<aff id="A4"><label>d</label>Department of Radiation Oncology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States</aff>
<aff id="A5"><label>e</label>Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States</aff>
<aff id="A6"><label>f</label>Department of Ophthalmology, University of Illinois at Chicago, Chicago, IL, United States</aff>
<aff id="A7"><label>g</label>Division of Comparative Pathology, Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States</aff>
<aff id="A8"><label>h</label>Bernard and Shirlee Brown Glaucoma Laboratory and Barbara &amp; Donald Jonas Laboratory of Regenerative Medicine, Columbia University, New York, NY, United States</aff>
<aff id="A9"><label>i</label>Edward S. Harkness Eye Institute, Columbia University, New York, NY, United States</aff>
<aff id="A10"><label>j</label>Departments of Ophthalmology, Pathology &amp; Cell Biology, and Institute of Human Nutrition, Columbia University, New York, NY, United States</aff>
<aff id="A11"><label>k</label>Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, United States</aff>
<aff id="A12"><label>l</label>Department of Veterans Affairs Iowa City Health Care System, Iowa City, IA, United States</aff>
<aff id="A13"><label>m</label>Veterans Affairs Center for the Prevention and Treatment of Visual Loss, Iowa City, IA, United States</aff>
<aff id="A14"><label>n</label>Palo Alto Veterans Administration, Palo Alto, CA, United States</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author at: Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA 94304, United States. E-mail address: <email>vinit.mahajan@stanford.edu</email> (V.B. Mahajan).</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P46">Conflict of interest disclosures</p>
<p id="P47">None reported.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>20</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>124</volume>
<fpage>408</fpage>
<lpage>419</lpage>
<!--elocation-id from pubmed: 10.1016/j.freeradbiomed.2018.06.024-->
<abstract id="ABS1">
<p id="P1">Oxidative stress is a pathogenic feature in vitreoretinal disease. However, the ability of the inner retina to manage metabolic waste and oxidative stress is unknown. Proteomic analysis of antioxidants in the human vitreous, the extracellular matrix opposing the inner retina, identified superoxide dismutase-3 (SOD3) that localized to a unique matrix structure in the vitreous base and cortex. To determine the role of SOD3, <italic>Sod3</italic><sup><italic>−/−</italic></sup> mice underwent histological and clinical phenotyping. Although the eyes were structurally normal, at the vitreoretinal interface <italic>Sod3</italic><sup><italic>−/−</italic></sup> mice demonstrated higher levels of 3-nitrotyrosine, a key marker of oxidative stress. Pattern electroretinography also showed physiological signaling abnormalities within the inner retina. Vitreous biopsies and epiretinal membranes collected from patients with diabetic vitreoretinopathy (DVR) and a mouse model of DVR showed significantly higher levels of nitrates and/or 3-nitrotyrosine oxidative stress biomarkers suggestive of SOD3 dysfunction. This study analyzes the molecular pathways that regulate oxidative stress in human vitreous substructures. The absence or dysregulation of the SOD3 antioxidant at the vitreous base and cortex results in increased oxidative stress and tissue damage to the inner retina, which may underlie DVR pathogenesis and other vitreoretinal diseases.</p>
</abstract>
<kwd-group>
<kwd>Knockout mouse</kwd>
<kwd>Diabetic retinopathy</kwd>
<kwd>Vitreous substructures</kwd>
<kwd>Antioxidant</kwd>
<kwd>Metabolic dysregulation</kwd>
<kwd>Proteomics</kwd>
<kwd>Extracellular matrix</kwd>
<kwd>Vitreous base</kwd>
<kwd>Vitreous cortex</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>